Harpoon Therapeutics Inc. (HARP) NASDAQ

$2.16 0.09 (4.11%)

Market Cap: $68.48M

As of 08/10/22 03:45 PM EDT. Market closed.

(HARP)

Harpoon Therapeutics Inc. (HARP) NASDAQ

$2.16 0.09 (4.11%)

Market Cap: $68.48M

As of 08/10/22 03:45 PM EDT. Market closed.

Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient's own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its ... read more

Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient's own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct (TriTAC®) platform, Harpoon is developing a pipeline of novel TriTACs initially focused on the treatment of solid tumors and hematologic malignancies. HPN424 targets PSMA and is in a Phase 1/2a trial for metastatic castration-resistant prostate cancer. HPN536 targets mesothelin and is in a Phase 1/2a trial for cancers expressing mesothelin, initially focused on ovarian and pancreatic cancers. HPN217 targets BCMA and is in a Phase 1/2 trial for relapsed, refractory multiple myeloma. HPN328 targets DLL3 and is in a Phase 1/2 trial for small cell lung cancer and other DLL3-associated tumors. Harpoon has also developed a proprietary ProTriTAC™ platform, which applies a prodrug concept to its TriTAC platform to create a therapeutic T cell engager that remains inactive until it reaches the tumor. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Gerald McMahon
Full Time Employees
78
URL
Address
131 Oyster Point Blvd Ste 300, California, South San Francisco, 94080-1910.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Gerald McMahon
Full Time Employees
78
Address
131 Oyster Point Blvd Ste 300, California, South San Francisco, 94080-1910.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$2.14
Previous Close
$2.07
Days Range
$2.01 - $2.21
52 week range
$1.73 - $9.94
Volume
72,455
Avg. Volume (30 days)
114,521
Market Cap
$68.48M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
33,084,139
Open
$2.14
Previous Close
$2.07
Days Range
$2.01 - $2.21
52 week range
$1.73 - $9.94
Volume
72,455
Avg. Volume (30 days)
114,521
Market Cap
$68.48M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
33,084,139

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR HARPOON THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Erbez Georgia Chief Financial Officer Sep 22, 2021 Buy $8.10 10,300 83,430 19,215 Sep 22, 2021, 09:30 PM
New Leaf Ventures III, L.P. 10% Owner Jan 11, 2021 Buy $17.00 235,294 3,999,998 913,860 Aug 12, 2021, 04:15 PM
HUNT RONALD Director Jan 11, 2021 Buy $17.00 235,294 3,999,998 913,860 Aug 12, 2021, 04:15 PM
Wesche Holger Chief Scientific Officer Jul 01, 2021 Option Exercise $0.60 10,000 6,000 62,852 Jul 06, 2021, 06:01 PM
Wesche Holger Chief Scientific Officer Jul 01, 2021 Sale $14.00 10,000 140,000 52,852 Jul 06, 2021, 06:01 PM
GADICKE ANSBERT 10% Owner May 28, 2021 Sale $21.12 13,885 293,315 6,374,904 Jun 02, 2021, 06:09 PM
GADICKE ANSBERT 10% Owner Jun 02, 2021 Sale $20.50 25,118 514,919 6,328,095 Jun 02, 2021, 06:09 PM
GADICKE ANSBERT 10% Owner Jun 01, 2021 Sale $20.44 18,491 377,956 6,353,213 Jun 02, 2021, 06:09 PM
GADICKE ANSBERT 10% Owner May 27, 2021 Sale $20.26 13,961 282,850 6,385,589 May 27, 2021, 07:40 PM
GADICKE ANSBERT 10% Owner May 26, 2021 Sale $20.04 3,198 64,088 6,399,550 May 27, 2021, 07:40 PM
GADICKE ANSBERT 10% Owner May 24, 2021 Sale $20.12 5,000 100,600 6,402,748 May 24, 2021, 08:11 PM
GADICKE ANSBERT 10% Owner May 21, 2021 Sale $20.21 10,907 220,430 6,407,748 May 24, 2021, 08:11 PM
GADICKE ANSBERT 10% Owner May 20, 2021 Sale $20.34 11,713 238,242 6,418,655 May 20, 2021, 07:20 PM
GADICKE ANSBERT 10% Owner May 19, 2021 Sale $20.39 17,833 363,615 6,430,368 May 20, 2021, 07:20 PM
GADICKE ANSBERT 10% Owner May 18, 2021 Sale $20.67 18,402 380,369 6,448,201 May 20, 2021, 07:20 PM
GADICKE ANSBERT 10% Owner May 13, 2021 Sale $20.06 4,855 97,391 6,478,169 May 17, 2021, 05:23 PM
GADICKE ANSBERT 10% Owner May 17, 2021 Sale $20.07 4,666 93,647 6,466,603 May 17, 2021, 05:23 PM
GADICKE ANSBERT 10% Owner May 14, 2021 Sale $20.04 6,900 138,276 6,471,269 May 17, 2021, 05:23 PM
GADICKE ANSBERT 10% Owner May 05, 2021 Sale $22.52 10,172 229,107 6,551,345 May 06, 2021, 04:05 PM
GADICKE ANSBERT 10% Owner Apr 21, 2021 Sale $18.97 8,972 170,229 7,020,675 Apr 22, 2021, 04:04 PM
GADICKE ANSBERT 10% Owner Apr 20, 2021 Sale $18.71 22,249 416,382 7,029,926 Apr 20, 2021, 06:07 PM
GADICKE ANSBERT 10% Owner Apr 19, 2021 Sale $19.30 10,056 194,059 7,051,441 Apr 20, 2021, 06:07 PM
GADICKE ANSBERT 10% Owner Apr 16, 2021 Sale $19.86 5,847 116,110 7,061,697 Apr 20, 2021, 06:07 PM
MPM BioVentures 2014, L.P. Former 10% Owner Apr 13, 2021 Sale $19.46 1,943 37,806 3,223,853 Apr 15, 2021, 08:01 PM
MPM BioVentures 2014, L.P. Former 10% Owner Apr 15, 2021 Sale $20.49 1,052 21,555 3,220,844 Apr 15, 2021, 08:01 PM
MPM BioVentures 2014, L.P. Former 10% Owner Apr 14, 2021 Sale $20.77 1,671 34,714 3,223,446 Apr 15, 2021, 08:01 PM
GADICKE ANSBERT 10% Owner Apr 15, 2021 Sale $20.49 8,696 178,181 7,067,244 Apr 15, 2021, 08:00 PM
GADICKE ANSBERT 10% Owner Apr 14, 2021 Sale $20.77 13,806 286,809 7,088,746 Apr 15, 2021, 08:00 PM
GADICKE ANSBERT 10% Owner Apr 13, 2021 Sale $19.46 16,054 312,369 7,092,108 Apr 15, 2021, 08:00 PM
MPM BioVentures 2014, L.P. 10% Owner Apr 12, 2021 Sale $21.02 2,496 52,460 3,226,369 Apr 13, 2021, 04:12 PM
MPM BioVentures 2014, L.P. 10% Owner Apr 09, 2021 Sale $23.67 10,300 243,801 3,228,006 Apr 13, 2021, 04:12 PM
Wesche Holger Chief Scientific Officer Apr 01, 2021 Option Exercise $0.60 10,000 6,000 62,852 Apr 05, 2021, 05:00 PM
Wesche Holger Chief Scientific Officer Apr 01, 2021 Sale $20.45 10,000 204,491 53,352 Apr 05, 2021, 05:00 PM
Erbez Georgia Chief Financial Officer Feb 17, 2021 Option Exercise $2.12 25,000 53,000 72,292 Feb 18, 2021, 08:31 AM
MPM BioVentures 2014, L.P. 10% Owner Feb 10, 2021 Sale $20.00 183,051 3,661,020 3,238,306 Feb 12, 2021, 05:03 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 10, 2021 Sale $20.00 183,051 3,661,020 3,238,306 Feb 12, 2021, 05:03 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 09, 2021 Sale $20.25 9,400 190,350 3,421,357 Feb 09, 2021, 06:14 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 08, 2021 Sale $20.04 72,128 1,445,445 3,430,757 Feb 09, 2021, 06:14 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 05, 2021 Sale $20.01 10,172 203,542 3,502,885 Feb 09, 2021, 06:14 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 04, 2021 Sale $20.37 29,730 605,600 3,513,057 Feb 04, 2021, 07:30 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 03, 2021 Sale $20.21 41,922 847,244 3,542,787 Feb 04, 2021, 07:30 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 02, 2021 Sale $20.13 48,421 974,715 3,584,709 Feb 04, 2021, 07:30 PM
MPM BioVentures 2014, L.P. 10% Owner Jan 25, 2021 Sale $21.23 13,006 276,117 4,341,318 Jan 27, 2021, 08:35 PM
MPM BioVentures 2014, L.P. 10% Owner Jan 27, 2021 Sale $20.00 706,825 14,136,500 3,633,130 Jan 27, 2021, 08:35 PM
MPM BioVentures 2014, L.P. 10% Owner Jan 26, 2021 Sale $21.08 1,363 28,732 4,339,955 Jan 27, 2021, 08:35 PM
MPM BioVentures 2014, L.P. 10% Owner Jan 22, 2021 Sale $21.72 24,695 536,375 4,354,324 Jan 22, 2021, 08:16 PM
MPM BioVentures 2014, L.P. 10% Owner Jan 21, 2021 Sale $22.22 26,066 579,095 4,384,106 Jan 22, 2021, 08:16 PM
MPM BioVentures 2014, L.P. 10% Owner Jan 20, 2021 Sale $24.04 17,694 425,291 4,508,731 Jan 22, 2021, 08:16 PM
Wesche Holger Chief Scientific Officer Jan 04, 2021 Option Exercise $0.60 10,000 6,000 62,852 Jan 06, 2021, 06:25 PM
Wesche Holger Chief Scientific Officer Jan 04, 2021 Sale $18.38 10,000 183,837 59,752 Jan 06, 2021, 06:25 PM
Wesche Holger Chief Scientific Officer Oct 01, 2020 Option Exercise $0.60 10,000 6,000 62,669 Oct 05, 2020, 04:25 PM
Wesche Holger Chief Scientific Officer Oct 01, 2020 Sale $16.27 10,000 162,737 53,669 Oct 05, 2020, 04:25 PM
Erbez Georgia Chief Financial Officer Aug 19, 2020 Buy $11.40 5,000 57,000 8,915 Aug 20, 2020, 06:36 PM
Erbez Georgia Chief Financial Officer Aug 18, 2020 Buy $11.60 2,098 24,337 3,915 Aug 20, 2020, 06:36 PM
Erbez Georgia Chief Financial Officer Jul 31, 2020 Buy $10.92 1,817 19,842 1,817 Aug 04, 2020, 08:32 AM
Wesche Holger Chief Scientific Officer Jul 01, 2020 Option Exercise $0.60 10,000 6,000 62,669 Jul 02, 2020, 07:18 PM
Wesche Holger Chief Scientific Officer Jul 01, 2020 Sale $16.20 10,000 161,989 52,669 Jul 02, 2020, 07:18 PM
Arix Bioscience plc 10% Owner May 28, 2020 Sale $21.33 366,591 7,820,926 2,193,704 May 29, 2020, 04:32 PM
Arix Bioscience plc 10% Owner May 27, 2020 Sale $22.39 12,064 270,144 2,560,295 May 29, 2020, 04:32 PM
Sacks Natalie Chief Medical Officer May 18, 2020 Option Exercise $2.12 1,522 3,227 47,276 May 20, 2020, 06:34 PM
Sacks Natalie Chief Medical Officer May 18, 2020 Sale $14.77 1,522 22,479 45,754 May 20, 2020, 06:34 PM
Wesche Holger Chief Scientific Officer May 12, 2020 Option Exercise $0.60 1,400 840 54,069 May 13, 2020, 08:45 PM
Wesche Holger Chief Scientific Officer May 12, 2020 Sale $14.09 1,400 19,720 52,669 May 13, 2020, 08:45 PM
Wesche Holger Chief Scientific Officer May 08, 2020 Option Exercise $0.60 1,000 600 53,669 May 11, 2020, 09:37 PM
Wesche Holger Chief Scientific Officer May 07, 2020 Option Exercise $0.60 5,350 3,210 58,019 May 11, 2020, 09:37 PM
Wesche Holger Chief Scientific Officer May 11, 2020 Option Exercise $0.60 1,000 600 53,669 May 11, 2020, 09:37 PM
Wesche Holger Chief Scientific Officer May 08, 2020 Sale $14.00 1,000 14,000 52,669 May 11, 2020, 09:37 PM
Wesche Holger Chief Scientific Officer May 07, 2020 Sale $14.13 5,350 75,576 52,669 May 11, 2020, 09:37 PM
Wesche Holger Chief Scientific Officer May 11, 2020 Sale $14.07 1,000 14,065 52,669 May 11, 2020, 09:37 PM
Sacks Natalie Chief Medical Officer May 01, 2020 Option Exercise $2.12 5,826 12,351 51,580 May 05, 2020, 04:35 PM
Sacks Natalie Chief Medical Officer May 01, 2020 Sale $12.07 5,826 70,301 45,754 May 05, 2020, 04:35 PM
Wesche Holger Chief Scientific Officer Apr 28, 2020 Option Exercise $0.60 1,250 750 53,919 Apr 30, 2020, 04:58 PM
Wesche Holger Chief Scientific Officer Apr 28, 2020 Sale $14.05 1,250 17,565 52,669 Apr 30, 2020, 04:58 PM
Sacks Natalie Chief Medical Officer Apr 16, 2020 Option Exercise $2.12 500 1,060 46,254 Apr 17, 2020, 07:10 PM
Sacks Natalie Chief Medical Officer Apr 17, 2020 Option Exercise $2.12 1,021 2,165 46,775 Apr 17, 2020, 07:10 PM
Sacks Natalie Chief Medical Officer Apr 17, 2020 Sale $12.08 1,021 12,330 45,754 Apr 17, 2020, 07:10 PM
Sacks Natalie Chief Medical Officer Apr 16, 2020 Sale $12.00 500 6,000 45,754 Apr 17, 2020, 07:10 PM
Sacks Natalie Chief Medical Officer Apr 13, 2020 Option Exercise $2.12 4,556 9,659 50,310 Apr 15, 2020, 04:48 PM
Sacks Natalie Chief Medical Officer Apr 13, 2020 Sale $12.06 4,556 54,959 45,754 Apr 15, 2020, 04:48 PM
Sacks Natalie Chief Medical Officer Apr 06, 2020 Option Exercise $2.12 700 1,484 46,454 Apr 08, 2020, 06:10 PM
Sacks Natalie Chief Medical Officer Apr 07, 2020 Option Exercise $2.12 570 1,208 46,324 Apr 08, 2020, 06:10 PM
Sacks Natalie Chief Medical Officer Apr 06, 2020 Sale $12.00 700 8,401 45,754 Apr 08, 2020, 06:10 PM
Sacks Natalie Chief Medical Officer Apr 07, 2020 Sale $12.00 570 6,840 45,754 Apr 08, 2020, 06:10 PM
Sacks Natalie Chief Medical Officer Mar 17, 2020 Option Exercise $2.12 1,520 3,222 47,274 Mar 18, 2020, 05:28 PM
Sacks Natalie Chief Medical Officer Mar 16, 2020 Option Exercise $2.12 1 2 45,755 Mar 18, 2020, 05:28 PM
Sacks Natalie Chief Medical Officer Mar 17, 2020 Sale $12.00 1,520 18,240 45,754 Mar 18, 2020, 05:28 PM
Sacks Natalie Chief Medical Officer Mar 16, 2020 Sale $12.00 1 12 45,754 Mar 18, 2020, 05:28 PM
Sacks Natalie Chief Medical Officer Mar 02, 2020 Option Exercise $2.12 5,826 12,351 51,580 Mar 03, 2020, 09:31 PM
Sacks Natalie Chief Medical Officer Mar 02, 2020 Sale $14.68 5,826 85,526 45,754 Mar 03, 2020, 09:31 PM
Sacks Natalie Chief Medical Officer Feb 18, 2020 Option Exercise $2.12 1,521 3,225 47,275 Feb 20, 2020, 05:11 PM
Sacks Natalie Chief Medical Officer Feb 18, 2020 Sale $15.00 1,521 22,815 45,754 Feb 20, 2020, 05:11 PM
Sacks Natalie Chief Medical Officer Feb 03, 2020 Option Exercise $2.12 5,826 12,351 51,580 Feb 04, 2020, 08:11 PM
Sacks Natalie Chief Medical Officer Feb 03, 2020 Sale $13.90 5,826 81,006 45,754 Feb 04, 2020, 08:11 PM
Erbez Georgia Chief Financial Officer Jan 21, 2020 Buy $14.09 6,700 94,418 6,700 Jan 23, 2020, 08:34 AM
Sacks Natalie Chief Medical Officer Jan 16, 2020 Option Exercise $2.12 1,521 3,225 47,275 Jan 21, 2020, 08:05 PM
Sacks Natalie Chief Medical Officer Jan 16, 2020 Sale $14.94 1,521 22,725 45,754 Jan 21, 2020, 08:05 PM
Wesche Holger Chief Scientific Officer Jan 02, 2020 Option Exercise $0.60 10,000 6,000 62,669 Jan 06, 2020, 09:55 PM
Wesche Holger Chief Scientific Officer Jan 02, 2020 Sale $14.40 10,000 143,987 52,669 Jan 06, 2020, 09:55 PM
Sacks Natalie Chief Medical Officer Jan 02, 2020 Option Exercise $2.12 5,826 12,351 51,580 Jan 06, 2020, 09:46 PM
Sacks Natalie Chief Medical Officer Jan 02, 2020 Sale $14.18 5,826 82,600 45,754 Jan 06, 2020, 09:46 PM
Baeuerle Patrick Director Dec 27, 2019 Sale $15.98 87,379 1,396,281 273,953 Dec 30, 2019, 05:32 PM
Sacks Natalie Chief Medical Officer Dec 16, 2019 Option Exercise $2.12 1,521 3,225 47,275 Dec 18, 2019, 04:14 PM
Sacks Natalie Chief Medical Officer Dec 16, 2019 Sale $17.02 1,521 25,888 45,754 Dec 18, 2019, 04:14 PM
Chin Mark Director Dec 17, 2019 Sale $16.83 12,476 209,969 2,572,359 Dec 17, 2019, 09:23 PM
Chin Mark Director Dec 16, 2019 Sale $17.02 13,080 222,680 2,584,835 Dec 17, 2019, 09:23 PM
Chin Mark Director Dec 13, 2019 Sale $17.21 11,002 189,341 2,597,915 Dec 17, 2019, 09:23 PM
Arix Bioscience plc 10% Owner Dec 13, 2019 Sale $17.21 11,002 189,341 2,597,915 Dec 17, 2019, 07:20 PM
Arix Bioscience plc 10% Owner Dec 17, 2019 Sale $16.83 12,476 209,969 2,572,359 Dec 17, 2019, 07:20 PM
Arix Bioscience plc 10% Owner Dec 16, 2019 Sale $17.02 13,080 222,680 2,584,835 Dec 17, 2019, 07:20 PM
Chin Mark Director Dec 10, 2019 Sale $16.91 131,696 2,227,019 2,608,917 Dec 10, 2019, 08:07 PM
Chin Mark Director Dec 09, 2019 Sale $18.16 103,754 1,884,445 2,817,929 Dec 10, 2019, 08:07 PM
Chin Mark Director Dec 06, 2019 Sale $19.15 47,752 914,222 2,844,367 Dec 10, 2019, 08:07 PM
Arix Bioscience plc 10% Owner Dec 09, 2019 Sale $18.16 103,754 1,884,445 2,817,929 Dec 10, 2019, 07:27 PM
Arix Bioscience plc 10% Owner Dec 06, 2019 Sale $19.15 47,752 914,222 2,844,367 Dec 10, 2019, 07:27 PM
Arix Bioscience plc 10% Owner Dec 10, 2019 Sale $16.91 131,696 2,227,019 2,608,917 Dec 10, 2019, 07:27 PM
Erbez Georgia Chief Financial Officer Dec 04, 2019 Option Exercise $2.12 47,292 100,259 47,292 Dec 06, 2019, 04:41 PM
Sacks Natalie Chief Medical Officer Dec 02, 2019 Option Exercise $2.12 5,826 12,351 51,580 Dec 04, 2019, 04:42 PM
Sacks Natalie Chief Medical Officer Dec 02, 2019 Sale $17.98 5,826 104,751 45,754 Dec 04, 2019, 04:42 PM
Sacks Natalie Chief Medical Officer Nov 18, 2019 Option Exercise $2.12 18,252 38,694 64,006 Nov 19, 2019, 04:24 PM
Sacks Natalie Chief Medical Officer Nov 18, 2019 Sale $13.37 18,252 243,964 46,754 Nov 19, 2019, 04:24 PM
Sacks Natalie Chief Medical Officer Nov 01, 2019 Option Exercise $2.12 5,826 12,351 51,580 Nov 05, 2019, 04:09 PM
Sacks Natalie Chief Medical Officer Nov 01, 2019 Sale $13.17 5,826 76,702 45,754 Nov 05, 2019, 04:09 PM
Sacks Natalie Chief Medical Officer Oct 14, 2019 Option Exercise $2.12 12,452 26,398 58,206 Oct 16, 2019, 05:14 PM
Sacks Natalie Chief Medical Officer Oct 15, 2019 Option Exercise $2.12 11,698 24,800 57,452 Oct 16, 2019, 05:14 PM
Sacks Natalie Chief Medical Officer Oct 14, 2019 Sale $13.27 12,452 165,280 45,754 Oct 16, 2019, 05:14 PM
Sacks Natalie Chief Medical Officer Oct 15, 2019 Sale $13.21 11,698 154,481 45,754 Oct 16, 2019, 05:14 PM
McMahon Gerald PhD President and CEO Jun 05, 2019 Option Exercise $0.60 169,462 101,677 172,462 Sep 06, 2019, 07:17 PM
McMahon Gerald PhD President and CEO May 14, 2019 Buy $10.16 1,000 10,157 3,000 May 16, 2019, 08:32 AM
McMahon Gerald PhD President and CEO May 08, 2019 Buy $10.56 1,000 10,559 2,000 May 10, 2019, 08:31 AM
McMahon Gerald PhD President and CEO May 03, 2019 Buy $10.53 1,000 10,530 1,000 May 07, 2019, 04:12 PM
Arix Bioscience plc 10% Owner Feb 12, 2019 Buy $14.00 428,571 5,999,994 2,892,119 Feb 14, 2019, 06:01 PM
UBS Oncology Impact Fund L.P. 10% Owner Feb 12, 2019 Buy $14.00 250,000 3,500,000 3,898,422 Feb 14, 2019, 05:34 PM
UBS Oncology Impact Fund L.P. 10% Owner Feb 12, 2019 Sale $14.00 447 6,258 3,648,422 Feb 14, 2019, 05:34 PM
UBS Oncology Impact Fund L.P. 10% Owner Feb 12, 2019 Option Exercise $0.05 127,096 6,253 3,648,869 Feb 14, 2019, 05:34 PM
New Leaf Ventures III, L.P. 10% Owner Feb 12, 2019 Buy $14.00 428,571 5,999,994 2,242,839 Feb 14, 2019, 05:33 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 12, 2019 Buy $14.00 250,000 3,500,000 4,524,425 Feb 14, 2019, 05:32 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 12, 2019 Sale $14.00 1,524 21,336 4,274,425 Feb 14, 2019, 05:32 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 12, 2019 Option Exercise $0.05 432,119 21,260 4,275,949 Feb 14, 2019, 05:32 PM
HUNT RONALD Director Feb 12, 2019 Buy $14.00 428,571 5,999,994 2,242,839 Feb 14, 2019, 05:30 PM
GADICKE ANSBERT 10% Owner Feb 12, 2019 Buy $14.00 500,000 7,000,000 8,422,847 Feb 14, 2019, 05:28 PM
GADICKE ANSBERT 10% Owner Feb 12, 2019 Sale $14.00 1,971 27,594 7,922,847 Feb 14, 2019, 05:28 PM
GADICKE ANSBERT 10% Owner Feb 12, 2019 Option Exercise $0.05 559,215 27,513 7,924,818 Feb 14, 2019, 05:28 PM
Chin Mark Director Feb 12, 2019 Buy $14.00 428,571 5,999,994 2,892,119 Feb 14, 2019, 05:24 PM
EVNIN LUKE Director Feb 12, 2019 Option Exercise $14.00 1,524 21,336 4,274,425 Feb 14, 2019, 05:19 PM
EVNIN LUKE Director Feb 12, 2019 Buy $14.00 250,000 3,500,000 4,524,425 Feb 14, 2019, 05:19 PM
EVNIN LUKE Director Feb 12, 2019 Option Exercise $0.05 432,119 21,260 4,275,949 Feb 14, 2019, 05:19 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Erbez Georgia Chief Financial Officer 09/22/2021 83,430
New Leaf Ventures III, L.P. 10% Owner 01/11/2021 3,999,998
HUNT RONALD Director 01/11/2021 3,999,998
Wesche Holger Chief Scientific Officer 07/01/2021 6,000
Wesche Holger Chief Scientific Officer 07/01/2021 140,000
GADICKE ANSBERT 10% Owner 05/28/2021 293,315
GADICKE ANSBERT 10% Owner 06/02/2021 514,919
GADICKE ANSBERT 10% Owner 06/01/2021 377,956
GADICKE ANSBERT 10% Owner 05/27/2021 282,850
GADICKE ANSBERT 10% Owner 05/26/2021 64,088
GADICKE ANSBERT 10% Owner 05/24/2021 100,600
GADICKE ANSBERT 10% Owner 05/21/2021 220,430
GADICKE ANSBERT 10% Owner 05/20/2021 238,242
GADICKE ANSBERT 10% Owner 05/19/2021 363,615
GADICKE ANSBERT 10% Owner 05/18/2021 380,369
GADICKE ANSBERT 10% Owner 05/13/2021 97,391
GADICKE ANSBERT 10% Owner 05/17/2021 93,647
GADICKE ANSBERT 10% Owner 05/14/2021 138,276
GADICKE ANSBERT 10% Owner 05/05/2021 229,107
GADICKE ANSBERT 10% Owner 04/21/2021 170,229
GADICKE ANSBERT 10% Owner 04/20/2021 416,382
GADICKE ANSBERT 10% Owner 04/19/2021 194,059
GADICKE ANSBERT 10% Owner 04/16/2021 116,110
MPM BioVentures 2014, L.P. Former 10% Owner 04/13/2021 37,806
MPM BioVentures 2014, L.P. Former 10% Owner 04/15/2021 21,555
MPM BioVentures 2014, L.P. Former 10% Owner 04/14/2021 34,714
GADICKE ANSBERT 10% Owner 04/15/2021 178,181
GADICKE ANSBERT 10% Owner 04/14/2021 286,809
GADICKE ANSBERT 10% Owner 04/13/2021 312,369
MPM BioVentures 2014, L.P. 10% Owner 04/12/2021 52,460
MPM BioVentures 2014, L.P. 10% Owner 04/09/2021 243,801
Wesche Holger Chief Scientific Officer 04/01/2021 6,000
Wesche Holger Chief Scientific Officer 04/01/2021 204,491
Erbez Georgia Chief Financial Officer 02/17/2021 53,000
MPM BioVentures 2014, L.P. 10% Owner 02/10/2021 3,661,020
MPM BioVentures 2014, L.P. 10% Owner 02/10/2021 3,661,020
MPM BioVentures 2014, L.P. 10% Owner 02/09/2021 190,350
MPM BioVentures 2014, L.P. 10% Owner 02/08/2021 1,445,445
MPM BioVentures 2014, L.P. 10% Owner 02/05/2021 203,542
MPM BioVentures 2014, L.P. 10% Owner 02/04/2021 605,600
MPM BioVentures 2014, L.P. 10% Owner 02/03/2021 847,244
MPM BioVentures 2014, L.P. 10% Owner 02/02/2021 974,715
MPM BioVentures 2014, L.P. 10% Owner 01/25/2021 276,117
MPM BioVentures 2014, L.P. 10% Owner 01/27/2021 14,136,500
MPM BioVentures 2014, L.P. 10% Owner 01/26/2021 28,732
MPM BioVentures 2014, L.P. 10% Owner 01/22/2021 536,375
MPM BioVentures 2014, L.P. 10% Owner 01/21/2021 579,095
MPM BioVentures 2014, L.P. 10% Owner 01/20/2021 425,291
Wesche Holger Chief Scientific Officer 01/04/2021 6,000
Wesche Holger Chief Scientific Officer 01/04/2021 183,837
Wesche Holger Chief Scientific Officer 10/01/2020 6,000
Wesche Holger Chief Scientific Officer 10/01/2020 162,737
Erbez Georgia Chief Financial Officer 08/19/2020 57,000
Erbez Georgia Chief Financial Officer 08/18/2020 24,337
Erbez Georgia Chief Financial Officer 07/31/2020 19,842
Wesche Holger Chief Scientific Officer 07/01/2020 6,000
Wesche Holger Chief Scientific Officer 07/01/2020 161,989
Arix Bioscience plc 10% Owner 05/28/2020 7,820,926
Arix Bioscience plc 10% Owner 05/27/2020 270,144
Sacks Natalie Chief Medical Officer 05/18/2020 3,227
Sacks Natalie Chief Medical Officer 05/18/2020 22,479
Wesche Holger Chief Scientific Officer 05/12/2020 840
Wesche Holger Chief Scientific Officer 05/12/2020 19,720
Wesche Holger Chief Scientific Officer 05/08/2020 600
Wesche Holger Chief Scientific Officer 05/07/2020 3,210
Wesche Holger Chief Scientific Officer 05/11/2020 600
Wesche Holger Chief Scientific Officer 05/08/2020 14,000
Wesche Holger Chief Scientific Officer 05/07/2020 75,576
Wesche Holger Chief Scientific Officer 05/11/2020 14,065
Sacks Natalie Chief Medical Officer 05/01/2020 12,351
Sacks Natalie Chief Medical Officer 05/01/2020 70,301
Wesche Holger Chief Scientific Officer 04/28/2020 750
Wesche Holger Chief Scientific Officer 04/28/2020 17,565
Sacks Natalie Chief Medical Officer 04/16/2020 1,060
Sacks Natalie Chief Medical Officer 04/17/2020 2,165
Sacks Natalie Chief Medical Officer 04/17/2020 12,330
Sacks Natalie Chief Medical Officer 04/16/2020 6,000
Sacks Natalie Chief Medical Officer 04/13/2020 9,659
Sacks Natalie Chief Medical Officer 04/13/2020 54,959
Sacks Natalie Chief Medical Officer 04/06/2020 1,484
Sacks Natalie Chief Medical Officer 04/07/2020 1,208
Sacks Natalie Chief Medical Officer 04/06/2020 8,401
Sacks Natalie Chief Medical Officer 04/07/2020 6,840
Sacks Natalie Chief Medical Officer 03/17/2020 3,222
Sacks Natalie Chief Medical Officer 03/16/2020 2
Sacks Natalie Chief Medical Officer 03/17/2020 18,240
Sacks Natalie Chief Medical Officer 03/16/2020 12
Sacks Natalie Chief Medical Officer 03/02/2020 12,351
Sacks Natalie Chief Medical Officer 03/02/2020 85,526
Sacks Natalie Chief Medical Officer 02/18/2020 3,225
Sacks Natalie Chief Medical Officer 02/18/2020 22,815
Sacks Natalie Chief Medical Officer 02/03/2020 12,351
Sacks Natalie Chief Medical Officer 02/03/2020 81,006
Erbez Georgia Chief Financial Officer 01/21/2020 94,418
Sacks Natalie Chief Medical Officer 01/16/2020 3,225
Sacks Natalie Chief Medical Officer 01/16/2020 22,725
Wesche Holger Chief Scientific Officer 01/02/2020 6,000
Wesche Holger Chief Scientific Officer 01/02/2020 143,987
Sacks Natalie Chief Medical Officer 01/02/2020 12,351
Sacks Natalie Chief Medical Officer 01/02/2020 82,600
Baeuerle Patrick Director 12/27/2019 1,396,281
Sacks Natalie Chief Medical Officer 12/16/2019 3,225
Sacks Natalie Chief Medical Officer 12/16/2019 25,888
Chin Mark Director 12/17/2019 209,969
Chin Mark Director 12/16/2019 222,680
Chin Mark Director 12/13/2019 189,341
Arix Bioscience plc 10% Owner 12/13/2019 189,341
Arix Bioscience plc 10% Owner 12/17/2019 209,969
Arix Bioscience plc 10% Owner 12/16/2019 222,680
Chin Mark Director 12/10/2019 2,227,019
Chin Mark Director 12/09/2019 1,884,445
Chin Mark Director 12/06/2019 914,222
Arix Bioscience plc 10% Owner 12/09/2019 1,884,445
Arix Bioscience plc 10% Owner 12/06/2019 914,222
Arix Bioscience plc 10% Owner 12/10/2019 2,227,019
Erbez Georgia Chief Financial Officer 12/04/2019 100,259
Sacks Natalie Chief Medical Officer 12/02/2019 12,351
Sacks Natalie Chief Medical Officer 12/02/2019 104,751
Sacks Natalie Chief Medical Officer 11/18/2019 38,694
Sacks Natalie Chief Medical Officer 11/18/2019 243,964
Sacks Natalie Chief Medical Officer 11/01/2019 12,351
Sacks Natalie Chief Medical Officer 11/01/2019 76,702
Sacks Natalie Chief Medical Officer 10/14/2019 26,398
Sacks Natalie Chief Medical Officer 10/15/2019 24,800
Sacks Natalie Chief Medical Officer 10/14/2019 165,280
Sacks Natalie Chief Medical Officer 10/15/2019 154,481
McMahon Gerald PhD President and CEO 06/05/2019 101,677
McMahon Gerald PhD President and CEO 05/14/2019 10,157
McMahon Gerald PhD President and CEO 05/08/2019 10,559
McMahon Gerald PhD President and CEO 05/03/2019 10,530
Arix Bioscience plc 10% Owner 02/12/2019 5,999,994
UBS Oncology Impact Fund L.P. 10% Owner 02/12/2019 3,500,000
UBS Oncology Impact Fund L.P. 10% Owner 02/12/2019 6,258
UBS Oncology Impact Fund L.P. 10% Owner 02/12/2019 6,253
New Leaf Ventures III, L.P. 10% Owner 02/12/2019 5,999,994
MPM BioVentures 2014, L.P. 10% Owner 02/12/2019 3,500,000
MPM BioVentures 2014, L.P. 10% Owner 02/12/2019 21,336
MPM BioVentures 2014, L.P. 10% Owner 02/12/2019 21,260
HUNT RONALD Director 02/12/2019 5,999,994
GADICKE ANSBERT 10% Owner 02/12/2019 7,000,000
GADICKE ANSBERT 10% Owner 02/12/2019 27,594
GADICKE ANSBERT 10% Owner 02/12/2019 27,513
Chin Mark Director 02/12/2019 5,999,994
EVNIN LUKE Director 02/12/2019 21,336
EVNIN LUKE Director 02/12/2019 3,500,000
EVNIN LUKE Director 02/12/2019 21,260
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
09/30/2021
0.31%
1Q
12/31/2021
03/31/2021
2.20%
3Q
12/31/2021
12/31/2020
28.92%
4Q
12/31/2021
09/30/2020
29.65%
5Q
12/31/2021
03/31/2020
30.01%
7Q
12/31/2021
12/31/2019
48.41%
8Q
Load More

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
0.31%
1Q
03/31/2021
2.20%
3Q
12/31/2020
28.92%
4Q
09/30/2020
29.65%
5Q
03/31/2020
30.01%
7Q
12/31/2019
48.41%
8Q
Load More